entertainment -WSS

entertainment

author：explore 2025-09-28 21:06:25 - browse：9

Amedisys -- Hospital coverage from STAT — Option Care Health is buying Amedisys, creating a national company that specializes in almost all types of home care. Wikimedia Commons

Option Care Health is buying Amedisys in an all-stock merger valued at $3.6 billion, creating a national company that specializes in almost all types of home care that can be provided from cradle to grave.

Health insurance companies, providers, and patients have pushed for more care to be handled at home instead of a hospital or post-acute facility, under the idea that quality home care saves money and is what patients want. Option Care’s deal for Amedisys marks another instance of this push, and comes just a few months after UnitedHealth Group closed on its $5.4 billion acquisition of LHC Group.

But Wall Street was not receptive to the deal, driving down Option Care’s stock by more than 25% on Thursday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Can we make enough H5N1 bird flu vaccine if there's a pandemic?

WSS

Novo Nordisk to expand supply of Wegovy for U.S. patients

Do digital therapeutics have a future in medicine?

When prostate cancer spreads, where it goes matters

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Commercial surrogacy can be ethical, despite pope’s claims

hotspot

entertainment

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Time to name cancers by genetics, not organ of origin, expert says

Activists slam private health insurers over coverage restrictions

Military medical care influenced by rank and race, new study finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

SAMSHA loosens regulations on methadone treatment centers

After affirmative action ruling, medical educators look to 'holistic review'

Helping hospitals and community health centers plan for resilience

Medical leaders decry Supreme Court decision on affirmative action

Even great ERs can’t make up for American health disparities

hotspot

FDA drug safety: Singulair case shows systemic surveillance flaws

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Medicare drug price negotiation’s day in court

Cognito secures funding to test medical device for Alzheimer's

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

FDA drug safety: Singulair case shows systemic surveillance flaws

leisure time

focus

focus

hotspot